Teva Provides 2011 Non-GAAP Financial Outlook

On its conference call today, Teva Pharmaceutical Industries Ltd. TEVA provided current outlook for its non-GAAP financial performance in 2011. For the full year, Teva expects net sales to be between $18.5 billion and $19.0 billion, with non-GAAP earnings per share (EPS) to be in the range of $4.90 to $5.20. Teva expects the second half of 2011 to be stronger than the first half and the second quarter to be stronger than the first quarter of 2011. Quarterly net sales and EPS results are expected to improve sequentially.